Experimental drug CR-001 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests an experimental drug called CR-001 in people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if CR-001 can slow or stop tumor growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a type of cancer that has spread or cannot be removed, such as liver, bile duct, endometrial, cervical, ovarian, stomach, colorectal, or lung cancer.
- You must be expected to live at least 3 more months.
- You must be well enough to do most daily activities on your own (ECOG score of 0 or 1).
- Your tumor must be measurable with a scan.
- You must be willing to give a fresh or stored tumor sample if needed for the higher-dose part of the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug, CRB-601-01, for people with advanced solid tumors that have not responded to other treatments. The goal is to see if it is safe and can help shrink tumors.
This early-phase trial tests a new drug (CD-001) for people with advanced solid tumors. It will check if the drug is safe, how the body handles it, and if it helps shrink tumors.
This trial is testing an experimental drug called MR001 (a bispecific antibody) for people with advanced solid tumors that have not responded to other treatments. The goal is to see if it is safe and how well it works.
This study tests a new cancer drug called NEOK001 that targets two proteins (B7-H3 and ROR1) found on certain tumor cells. The drug combines a cancer-fighting molecule with a toxic payload to kill cancer cells while sparing healthy tissue.
This Phase 1 trial tests BL-B01D1 in people with advanced or metastatic solid tumors that are not curable or lack standard treatment options. The goal is to see how the drug works in the body and whether it’s safe enough to study further.
This trial tests a new drug called FTL001 for people with advanced solid tumors that have not improved with standard therapy. The goal is to see if it is safe and how well it works.
Hear when a new Locally Advanced/Metastatic Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.